Invention Grant
![Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide](/docs/US/2018-05-15/US09969747B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide
-
Application No.: US15319995Application Date: 2015-06-18
-
Publication No.: US09969747B2Publication Date: 2018-05-15
- Inventor: Michael L. Hall
- Applicant: Constellation Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Michael J. DeGrazia
- International Application: PCT/US2015/036347 WO 20150618
- International Announcement: WO2015/195862 WO 20151223
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D498/04 ; C07D491/048
![Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide](/abs-image/US/2018/05/15/US09969747B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure relates to a crystalline form of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide, which is useful as an inhibitor of bromodomain-containing proteins. The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline form and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
Information query
